Hodgkin Lymphoma in HIV Positive Patients

Mounier, Nicolas; Spina, Michele; Spano, Jean P.
March 2010
Current HIV Research;Mar2010, Vol. 8 Issue 2, p141
Academic Journal
Hodgkin Lymphoma (HL) represents one of the most common types of a non-AIDS-defining tumour that occurs in the HIV population, and its incidence is increasing in the post Highly Active Anti-retroviral Therapy (HAART) era. Despite the aggressiveness of that disease, the outcome of patients with HIV-HL has improved with better, combined antineoplastic and antiretroviral approaches. New and effective antiretroviral drugs, in conjunction with nucleoside analogs, improve the control of the underlying HIV infection when used during treatment of HL with chemotherapy. The inclusion of hematopoietic growth factors in the treatment of patients with HIV-HL may allow for the administration of higher dose-intensity chemotherapy and the prolonged use of antiretroviral drugs, with the aim of improving the survival. In addition, new functional imaging tools, like the Positron Emission Tomography (PET), may help to guide treatment and minimize long term toxicity.


Related Articles

  • ORAL ABSTRACTS.  // Journal of the International AIDS Society;2014 Supplement 3, Vol. 17 Issue Supp 3, p439 

    The article presents abstracts on HIV drug therapy including curing HIV, normalisation of CD4/CD8 ratio with antiretroviral therapy in HIV infection and determinants of IL-6 levels during the HIV infection.

  • CD4+ T Follicular Helper and IgA+ B Cell Numbers in Gut Biopsies from HIV-Infected Subjects on Antiretroviral Therapy Are Similar to HIV-Uninfected Individuals. Zaunders, John; Danta, Mark; Bailey, Michelle; Mak, Gerald; Marks, Katherine; Seddiki, Nabila; Yin Xu; Templeton, David J.; Cooper, David A.; Boyd, Mark A.; Kelleher, Anthony D.; Koelsch, Kersten K. // Frontiers in Immunology;10/24/2016, Vol. 7, p1 

    Background: Disruption of gastrointestinal tract epithelial and immune barriers contribute to microbial translocation, systemic inflammation, and progression of HIV-1 infection. Antiretroviral therapy (ART) may lead to reconstitution of CD4+ T cells in gut-associated lymphoid tissue (GALT), but...

  • ORBITAL RHABDOMYOSARCOMA IN A 10-YEAR OLD HIV POSITIVE CHILD. H, Adil; S. T., Khairy-Shamel; I., Shatriah; I., Mohtar; E., Zunaina; S., Bakiah; Y., Rohaizan; A. W., Mohd Shuhaimi; A. P., Hilol; J., Hasnan // Malaysian Journal of Medical Sciences;Jan2007 Supplement, Vol. 14, p216 

    Introduction: Human immunodeficiency virus (HIV) infected patients are at risk of developing cancer, particularly Kaposi's sarcoma and non-Hodgkin's lymphoma. In contrast, rhabdomyosarcoma is the commonest primary orbital tumour in premorbidly healthy children. This case illustrates an uncommon...

  • Review: Thromboses among HIV-Infected Patients during the Highly Active Antiretroviral Therapy Era. Crum-Cianflone, Nancy F.; Weekes, Jhamillia; Bavaro, Mary // AIDS Patient Care & STDs;Oct2008, Vol. 22 Issue 10, p771 

    Venous thrombotic events (VTEs) may occur at higher rates among patients with HIV; some studies suggest that highly active antiretroviral therapy (HAART) may increase the risk for these potentially life-threatening events. We performed a retrospective study among patients with HIV to evaluate...

  • High Risk Features Contrast With Favorable Outcomes in HIV-associated Hodgkin Lymphoma in the Modern cART Era, ANRS CO16 LYMPHOVIR Cohort. Besson, Caroline; Lancar, Remi; Prevot, Sophie; Brice, Pauline; Meyohas, Marie-Caroline; Marchou, Bruno; Gabarre, Jean; Bonnet, Fabrice; Goujard, Cécile; Lambotte, Olivier; Boué, François; Mounier, Nicolas; Partisani, Marialuisa; Raffi, Francois; Costello, Régis; Hendel-Chavez, Houria; Algarte-Genin, Michele; Trabelsi, Selma; Marchand, Lucie; Raphael, Martine // Clinical Infectious Diseases;11/1/2015, Vol. 61 Issue 9, p1469 

    Background: Human immunodeficiency virus (HIV) infection is associated with a high risk of classical Hodgkin's lymphoma (cHL) in the combined antiretroviral therapy (cART) era. Methods: We analyzed the characteristics and outcome of HIV-associated cHL diagnosed in the modern cART era. The French...

  • The Evolving Scenario of Non-AIDS-Defining Cancers: Challenges and Opportunities of Care. Vaccher, Emanuela; Serraino, Diego; Carbone, Antonino; De Paoli, Paolo // Oncologist;Aug2014, Vol. 19 Issue 8, p860 

    Background. The impact of highly active antiretroviral therapies (HAART) on the risk of non-AIDS-defining cancers (NADCs) and the role of biological and clinical factors in their pathogenesis are debated issues. The purpose of this review is to examine the epidemiology, etiology, and...

  • HIV treatment prevents transmission of HIV.  // Africa Health;May2011, Vol. 33 Issue 4, p11 

    The article discusses the report from the US National Institutes of Health which found that an effective antiretroviral therapy regimen for HIV-positive person could prevent the risk of transmitting the virus to their uninfected sexual partner.

  • Detection of immunological treatment failure among HIV infected patients in Ethiopia: a retrospective cohort study. Teshome, Wondu; Tefera, Ambachew // BMC Immunology;9/17/2015, Vol. 16 Issue 1, p1 

    Background: Timely detection of treatment failure with subsequent switch to second-line regimen reduces mortality among HIV infected people on antiretroviral therapy (ART). This paper aims to investigate the detection of immunological treatment failure and switch rate to second line regimen in...

  • Risk of Cancer among Commercially Insured HIV-Infected Adults on Antiretroviral Therapy. Lee, Jeannette Y.; Dhakal, Ishwori; Casper, Corey; Noy, Ariela; Palefsky, Joel M.; Haigentz, Missak; Krown, Susan E.; Ambinder, Richard F.; Mitsuyasu, Ronald T. // Journal of Cancer Epidemiology;11/2/2016, p1 

    The objective of this study was to explore the cancer incidence rates among HIV-infected persons with commercial insurance who were on antiretroviral therapy and compare them with those rates in the general population. Paid health insurance claims for 63,221 individuals 18 years or older, with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics